Logo wahanariau.com
  2. Angelini pharma

Angelini pharma

Index
Globenewswire

Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease

Kamis, 07 Mei 2026 - 22:16:22 Wib
Globenewswire

Angelini Pharma Announces Appointment of Sergio Marullo di Condojanni as New CEO

Kamis, 22 Januari 2026 - 04:00:32 Wib
Globenewswire

Angelini Pharma Signs Exclusive Option Agreement With Sovargen To License Global Development and Commercialization Rights For Innovative Brain Health Asset

Selasa, 23 September 2025 - 02:45:42 Wib
Globenewswire

Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset

Senin, 21 Oktober 2024 - 12:00:00 Wib